Heightened proteasome function may possibly result in an increase of IκBα degradation and subsequently enhance NF-κB activation in multiple myeloma, as seen in pancreatic cancer cells (Ma et al., 2013). This evidence concerns the gene NFKB1 and plasma cell myeloma.